📰 Inflamm Bowel News
Inflamm Bowel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Inflamm Bowel. Real-time updates on events, politics, business and more.
October 24, 2023
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc.. The agreement includes the development, manufacturing and commercialisation rights in the US and Japan for ...
October 23, 2023
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc.. The agreement includes the development, manufacturing and commercialisation rights in the US and Japan for ...
October 23, 2023
Roche will gain the rights to develop, manufacture and commercialize RVT-3101 in the US and Japan for the treatment of inflammatory bowel disease and potentially multiple other diseasesRVT-3101 is a...
October 13, 2023
13.10.2023 - Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator for adults with moderately to severely ...
July 21, 2023
A single-center retrospective study is offering clinicians insight into the effects of biosimilar infliximab use on weight, height, and BMI trajectories in pediatric patients with inflammatory bowel disease.
March 30, 2023
−The Phase 4 EARNEST Study Met Its Primary Efficacy Endpoint of Remission of Chronic or Recurrent Pouchitis at Week 14, with 31% of Participants Receiving Vedolizumab Achieving Remission versus... | March 30, 2023
May 28, 2022
A broad overview of the role vitamin D in the immune system, especially in the pathogenesis & treatment of IBD, & its possible role in predicting relapse.
April 28, 2022
The validity of previously used register-based algorithms for capturing childhood-onset IBD has never been examined.
December 29, 2021
Investigating the contribution of protease-activated receptors to Crohn’s disease and ulcerative colitis and its implication for diagnosis and treatment
October 23, 2021
Hyperbaric therapy can be an effective adjunctive approach for inflammatory bowel disease- read the full article online